Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

AGM Update

14 Mar 2017 12:16

RNS Number : 4217Z
W.H. Ireland Group PLC
14 March 2017
 

WH Ireland Group Plc

("WH Ireland" or the "Company")

AGM Update

Further to the announcement of 27 February 2017 in which the Company announced it had dispatched a notice of Annual General Meeting to all shareholders ("AGM Notice"), the Company confirms that it has received notice from a shareholder proposing a minor amendment to Resolution 5 as set out in that AGM Notice.

The proposed amendment would, if passed, reduce the directors authority to allot equity securities pursuant to section 551 of the Companies Act 2006 as proposed in the AGM Notice to the authority to allot equity securities in connection with a pre-emptive rights issue up to an aggregate nominal value of £137,438, which is equal to ten per cent. of the nominal value of the issued ordinary share capital of the Company at 24 February 2017. The full text of resolution 5 as proposed to be amended is set out below:

Text of Resolution 5 (which is an ordinary resolution) as proposed to be amended

"5. That, in substitution for any equivalent existing and unexercised authorities and powers, the directors of the Company be and they are hereby generally and unconditionally authorised for the purpose of section 551 of the Companies Act 2006 (the "Act") to exercise all or any of the powers of the Company to allot shares of the Company or to grant rights to subscribe for, or to convert any security into, shares of the Company (such shares and rights being together referred to as "Relevant Securities") comprising equity securities (as defined in section 560(1) of the Act) up to an aggregate nominal amount of £137,437 in connection with a rights issue in favour of ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings and the directors may make such arrangements or exclusions as they consider necessary or appropriate to deal with fractional entitlements or any legal or practical difficulties under the laws of any territory or the requirements of any recognised regulatory body or stock exchange in any territory provided that this authority shall, unless previously renewed, varied or revoked by the Company in general meeting, expire at the conclusion of the next annual general meeting of the Company or on the date which is 6 months after the next accounting reference date of the Company (if earlier) save that the directors of the Company may, before the expiry of such period, make an offer or agreement which would or might require such securities to be allotted after the expiry of such period and the directors of the Company may allot such securities in pursuance of such offer or agreement as if the authority conferred hereby had not expired."

Following consultation with certain of its major shareholders, the board is pleased to confirm that they support the proposed amendment, which will be put to shareholders at the Company's AGM at 24 Martin Lane, London, EC4R 0DR on 30 March 2017 at 9.30 a.m. and recommends that shareholders vote in favour of the proposed amendment and, if passed, Resolution 5 as amended.

For further information please contact:

 

WH Ireland Group plc www.whirelandplc.com

Richard Killingbeck, Chief Executive Officer +44(0) 20 7220 1666

 

 

SPARK Advisory Partners Limited

Mark Brady/Miriam Greenwood

+44(0) 203 368 3551/3550

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUAGWUPMGPC
Date   Source Headline
17th Nov 202512:58 pmRNSForm 8.3 - W.H. Ireland Group PLC
14th Nov 202510:13 amRNSForm 8 (DD)
13th Nov 20259:39 amRNSForm 8.3 - WH Ireland Group plc
13th Nov 20259:37 amRNSDisclosure Table
13th Nov 20258:38 amRNSDisclosure Table
13th Nov 20257:49 amRNSDisclosure Table
13th Nov 20257:00 amRNSPossible Offer
5th Nov 20257:00 amRNSDirectorate Change
29th Oct 20257:00 amRNSDeferred Consideration re Capital Markets Division
27th Oct 20252:51 pmRNSResult of GM
27th Oct 20257:00 amRNSDirectorate Change
20th Oct 20251:49 pmRNSAdjournment of GM
16th Oct 20259:24 amRNSHolding(s) in Company
16th Oct 20259:23 amRNSHolding(s) in Company
9th Oct 20253:07 pmRNSResult of General Meeting
8th Oct 202510:21 amRNSResponse to Press Speculation
30th Sep 20253:23 pmRNSResult of AGM
26th Sep 20254:14 pmRNSFinal Results, Notice of GM and Annual Report
22nd Sep 20257:26 amRNSConditional disposal of Wealth Management Business
5th Sep 20257:00 amRNSNotice of AGM
10th Feb 20257:00 amRNSHenley Office
17th Dec 20241:17 pmRNSHolding(s) in Company
13th Dec 20247:04 amRNSInterim Results
17th Oct 20247:00 amRNSChange of Nominated Adviser and Broker
14th Oct 20247:00 amRNSNominated Adviser Status
30th Sep 20244:08 pmRNSResult of AGM
10th Sep 20249:51 amRNSHolding(s) in Company
30th Aug 202412:00 pmRNSNotice of AGM and Publication of Annual Report
22nd Aug 20245:46 pmRNSHolding(s) in Company
12th Aug 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSCompletion of Sale of the Capital Markets Division
27th Jun 20246:19 pmRNSHolding(s) in Company
27th Jun 20246:17 pmRNSHolding(s) in Company
26th Jun 202410:26 amRNSConfirmation of Chair Appointment
21st Jun 20248:09 amRNSDirector Notification
3rd Jun 20247:00 amRNSSale of Capital Markets Division & Trading Update
20th May 202411:14 amRNSResponse to Press Speculation
27th Dec 20237:00 amRNSInterim Results for Six Months ended 30 Sep 2023
16th Nov 20237:00 amRNSBoard Changes
24th Oct 20232:07 pmRNSResult of AGM
27th Sep 20237:00 amRNSFinal Results and Notice of AGM
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 202310:08 amRNSHolding(s) in Company
22nd Aug 202310:07 amRNSHolding(s) in Company
21st Aug 20239:26 amRNSHolding(s) in Company
18th Aug 202311:06 amRNSHolding(s) in Company
17th Aug 20235:14 pmRNSHolding(s) in Company
17th Aug 20234:09 pmRNSHolding(s) in Company
17th Aug 20239:16 amRNSHolding(s) in Company
16th Aug 20232:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.